Results 21 to 30 of about 810,423 (205)

Early Onset Outlet Obstruction of a Temporary Diverting Loop Ileostomy Secondary to Urinary Retention

open access: yesCase Reports in Gastroenterology, 2023
A mechanical obstruction is not a physiological entity, and when it occurs within the 30-day postoperative period, it is called an early postoperative small bowel obstruction.
Umut Akova   +3 more
doaj   +1 more source

Association between serum tumor necrosis factor-alpha level and the efficacy of infliximab for refractory pouchitis after restorative proctocolectomy in patients with ulcerative colitis

open access: yesJournal of the Anus, Rectum and Colon, 2017
Objectives: Although the aetiology of pouchitis after restorative proctocolectomy in ulcerative colitis (UC) remains unknown, infliximab (IFX) is often effective for this condition. However, indicators and predictors of treatment efficacy remain unclear.
Motoi Uchino   +7 more
doaj   +1 more source

Tacrolimus for ulcerative colitis in children: a multicenter survey in Japan [PDF]

open access: yesIntestinal Research, 2019
Background/Aims Tacrolimus is effective for refractory ulcerative colitis in adults, while data for children is sparse. We aimed to evaluate the effectiveness and safety of tacrolimus for induction and maintenance therapy in Japanese children with ...
Tadahiro Yanagi   +14 more
doaj   +1 more source

Malignancies in Inflammatory Bowel Disease [PDF]

open access: yesDigestion, 2020
<b><i>Background:</i></b> Inflammatory bowel disease (IBD) is a chronic inflammatory disorder, primarily of, but not restricted to, the gut. Association between IBD and cancer has been clearly established and is uniformly accepted.
Greuter, Thomas   +4 more
openaire   +6 more sources

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

open access: yesGut, 2019
Ulcerative colitis and Crohn’s disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and ...
C. Lamb   +41 more
semanticscholar   +1 more source

Associations between Pouchitis and Fecal Calprotectin after Restorative Proctocolectomy in Patients with Ulcerative Colitis

open access: yesInflammatory Intestinal Diseases, 2023
Introduction: Recently, fecal calprotectin has been identified and used as an assessment tool for the confirmation of disease activity in ulcerative colitis.
Motoi Uchino   +5 more
doaj   +1 more source

The four epidemiological stages in the global evolution of inflammatory bowel disease

open access: yesNature reviews: Gastroenterology & hepatology, 2020
Inflammatory bowel disease (IBD) is a global disease; its evolution can be stratified into four epidemiological stages: Emergence, Acceleration in Incidence, Compounding Prevalence and Prevalence Equilibrium.
G. Kaplan, J. Windsor
semanticscholar   +1 more source

Evidence-based clinical practice guidelines for inflammatory bowel disease 2020

open access: yesJournal of gastroenterology, 2021
Inflammatory bowel disease (IBD) is a general term for chronic or remitting/relapsing inflammatory diseases of the intestinal tract and generally refers to ulcerative colitis (UC) and Crohn’s disease (CD).
H. Nakase   +23 more
semanticscholar   +1 more source

Rectal-sparing type of ulcerative colitis predicts lack of response to pharmacotherapies

open access: yesBMC Surgery, 2017
Background Ulcerative colitis (UC) is known as an immune disorder of the colon that generally involves the rectum, but an atypical distribution of inflamed mucosa has previously been noted in certain subtypes of UC, such as the rectal-sparing type (RST).
Yuki Horio   +7 more
doaj   +1 more source

Review of the safety with biologics in inflammatory bowel disease

open access: yesJournal of IMIDs, 2022
Biologics have completely changed the treatment (and life) of patients with inflammatory bowel disease (IBD). After the first ones, anti-tumor necrosis factor (TNF) biologics, two new biologics, with other therapeutic targets, are now in routine use in ...
Andrea Pascual   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy